521 Episodo

  1. Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better?

    Publicado: 6/6/2023

  2. Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better?

    Publicado: 6/6/2023

  3. A Patient Is Waiting for a Liver Transplant: What Can We Do Now and What Could We Have Done Better?

    Publicado: 31/5/2023

  4. Reducing the Risks of Hyperkalemia in the Treatment of Heart Failure and Chronic Kidney Disease: What It Means for Management Teams

    Publicado: 31/5/2023

  5. Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations

    Publicado: 22/5/2023

  6. Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives

    Publicado: 8/5/2023

  7. Gaining Control With Early Combination Lipid-Lowering Therapy: Applying Learnings From the Queen's Gambit

    Publicado: 3/5/2023

  8. Looking Forward to Thriving With HIV: Interventions to Improve and Maintain Health in People With HIV

    Publicado: 1/5/2023

  9. Three Cardiovascular Risk Cases: Why and Who Should We Be Testing for Lp(a)

    Publicado: 18/4/2023

  10. Well Begun Is Half Done: Why and How Do We Assess Activity of the Complement Pathway in the Clinic?

    Publicado: 14/4/2023

  11. What’s New in Diabetic Eye Disease Technologies

    Publicado: 31/3/2023

  12. Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy

    Publicado: 30/3/2023

  13. Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases

    Publicado: 29/3/2023

  14. Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch

    Publicado: 29/3/2023

  15. Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies

    Publicado: 28/3/2023

  16. Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies

    Publicado: 27/3/2023

  17. Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm

    Publicado: 27/3/2023

  18. Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care?

    Publicado: 24/3/2023

  19. Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight

    Publicado: 23/3/2023

  20. What Is the Expert Accord on Identifying and Protecting the Patient at Early Stage of CKD?

    Publicado: 16/3/2023

8 / 27

Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.

Visit the podcast's native language site